Botanical species · safety record

Centaurea behen

The EFSA Compendium of Botanicals holds 8 constituent measurements for Centaurea behen. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Centaurea behen L.

8Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Aguirin b1
  • Cynaropicrin1
  • Desacylcynaropicrin1
  • Grosheimin1
  • Guaianolides1
  • Myrcene1
  • Solstitialin a1
  • Triterpene saponins1

Plant parts

  • Aerial part of plants5
  • Leaves1
  • Roots and other underground parts1
  • Unspecified1

Preparations

  • Solvent extraction6
  • Drying (dehydration)1
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GuaianolidesUnspecifiedSolvent extractionClassification not possibleResolve DOI
MyrceneAerial part of plantsEssential oil2.8 PercentGC-MSResolve DOI
Solstitialin aLeavesSolvent extractionResolve DOI
Aguirin bAerial part of plantsSolvent extractionNo resolvable identifier
CynaropicrinAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier
DesacylcynaropicrinAerial part of plantsSolvent extractionNo resolvable identifier
GrosheiminAerial part of plantsSolvent extractionNo resolvable identifier
Triterpene saponinsRoots and other underground partsDrying (dehydration)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yadava, R. N., Chakravarti, N. Novel bioactive triterpenoid saponin from Centaurea behen linn. Journal of the Institution of Chemists (India), 2006, p. 135-141.
  2. OKSUZ, S., ULUBELEN, A., AYNECHI, Y., WAGNER, H. A GUAIANOLIDE FROM CENTAUREA-BEHEN. PHYTOCHEMISTRY, 1982, vol. 21, no. 11, p. 2747-2749. DOI
  3. Rustaiyan, Abdolhossein., Niknejad, Akram., Zdero, Christa., Bohlmann, Ferdinand. Naturally occurring terpene derivatives. Part 352. A guaianolide from Centaurea behen. Phytochemistry (Elsevier), 1981, p. 2427-2429.
  4. Esmaeili, Akbar., Panahi, Zahra Ali., Ebrahimzadeh, Mohammad Ali. Investigation of Phytochemistry of Gene of Centaurea Grown in Iran. JOURNAL OF ESSENTIAL OIL BEARING PLANTS, 2014, vol. 17, no. 5, p. 806-812. DOI
  5. OKSUZ, S., CLARK, RJ., HERZ, W. A GUAIANOLIDE DIOL MONOACE ATE FROM CENTAUREA-BEHEN AND C-SOLSTITIFLIS SSP SCHOUWII. PHYTOCHEMISTRY, 1993, vol. 33, no. 5, p. 1267-1268. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue